LIVMARLI
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for LIVMARLI, covering 2021-09-29 to 2026-04-17. Get the full timeline:
Most recent: EMA Authorised: Livmarli (Maralixibat chloride) — Mirum Pharmaceuticals International B.V.